|
|
Home >
Services
> Lung Cancer
|
Lung Cancer Service
Lung cancer is common. It is the second
commonest incident cancer in men and women and the
commonest cause of cancer death in both sexes in the UK.
Lung cancer accounts for 1 in 15 deaths.More people die from lung cancer
than from breast, colon, ovary and pancreatic cancer combined, and
approximately 400 patients are investigated and diagnosed with lung
cancer within STH each year. |
 |
|
We are
fortunate to have a well integrated, multidisciplinary lung cancer
service in the Sheffield Teaching Hospitals NHS Foundation Trust, and
are the Cancer Centre for the
North Trent Cancer Network.
|
|
There are 2 weekly respiratory medicine clinics devoted to lung cancer: |
The Monday afternoon lung cancer clinic at RHH is preceded by the weekly
multidisciplinary meeting attended by:
- Consultant Respiratory Physicians (Drs
Chris Barber,
Jennifer Hill (Lead Lung Cancer Clinician) and
Rod
Lawson)
- Consultant Radiologist (Dr Rob Peck)
- Consultant Oncologists (Dr Trish Fisher
and Prof Penella Woll)
- Palliative Care Consultant (Prof Sam
Ahmedzai)
- Consultant Cardiothoracic Surgeon (Mr
Norman Briffa)
- Specialist Lung Cancer Nurse (Sr Helena
Stanley).
In addition, trainees from all disciplines
attend to learn about lung cancer. All patients suspected or known to
have lung cancer are discussed in this multidisciplinary forum and
management decisions planned by the team. The afternoon clinic is a
parallel clinic attended by 2 of the Respiratory Physicians, Clinical
Oncologist (Dr Fisher), the Palliative Care consultant and the
Specialist Lung Cancer Nurse (Sr Helena Stanley).
|
The weekly multidisciplinary team meeting at NGH occurs at 8.15 am on
Tuesday mornings and is attended by:
- Consultant Respiratory Physicians (Dr
Jennifer Hill,
Dr Paul Anderson)
- Consultant Oncologists (Dr Trish Fisher,
Prof Penella Woll)
- Consultant Thoracic Radiologists (Dr Sue
Matthews, Dr Catherine Hill, Dr Matthew Bull)
- Consultant Thoracic Surgeon (Mr W Zurek)
- Consultant Histopathologists (Dr Kim
Suvarna, Dr Yota Kitsanta, Dr Jeremy Hyde)
- Specialist Lung Cancer Nurses (Sr Anne
Clegg,
Sr Paula Munro).
|
|
Both MDTs are supported by dedicated clerical staff
(Cheryl Batten, Julie Key) who are responsible for ensuring that all the
clinical results and x-rays are available, and for arranging patient
appointments. A pathway co-ordinator (Paulette Afflick-Anderson) has
recently been appointed. As at RHH all patients suspected or known to
have lung cancer are discussed and a team management decision made.
Patients are seen at the weekly Wednesday morning parallel Lung Cancer
Clinic attended by the Respiratory Physicians, Oncologist (Dr Trish
Fisher), Palliative Care Consultant (Dr Kay Stewart) and the lung cancer
nurses.
Staging investigations
(including breathing tests, x-rays, CT scans, bronchoscopies and needle
biopsies) are carried out at each hospital site. A mobile PET scanner
attends the NGH site weekly. Patients requiring thoracic surgery are
admitted to the Chesterman Wing at NGH, where nurses, physiotherapists
and anaesthetists are experienced in the management of lung problems.
|
Chemotherapy and
radiotherapy treatments are delivered at Weston Park Hospital, where
there is a large team of specialist nurses, radiographers, pharmacists,
social workers, etc. Treatments are tailored to the needs of the
individual patients, taking into account their general health, the
stage and location of their tumour.
Many patients are offered a combination of different treatments, such as
surgery+chemotherapy or chemotherapy+radiotherapy. The full range of
treatments for lung cancer is available in Sheffield, including
hyperfractionated radiotherapy (CHART). Treatment is given in
accordance with
national guidelines and the latest
research evidence. As STHFT is the Cancer Centre for the North Trent
Cancer Network, patients from Barnsley, Chesterfield, Doncaster and
Rotherham hospitals who require chemotherapy, radiotherapy or thoracic
surgery are sent to Sheffield.
Many patients have the
opportunity to participate in cutting edge research studies, as
Sheffield leads the UK in recruitment to
national lung cancer trials. In
addition, Professor Woll leads a research team undertaking laboratory
based lung cancer research in the University of Sheffield.
|
 |
|
The subspeciality lead for Lung Cancer is Dr
Jennifer Hill.
Please contact her directly for further
information.
|
|
